Literature DB >> 8618823

Truncated WT1 mutants alter the subnuclear localization of the wild-type protein.

C Englert1, M Vidal, S Maheswaran, Y Ge, R M Ezzell, K J Isselbacher, D A Haber.   

Abstract

WT1 encodes a zinc-finger protein, expressed as distinct isoforms, that is inactivated in a subset of Wilms tumors. Both constitutional and somatic mutations disrupting the DNA-binding domain of WT1 result in a potentially dominant-negative phenotype. In generating inducible cell lines expressing wild-type isoforms of WT1 and WT1 mutants, we observed dramatic differences in the subnuclear localization of the induced proteins. The WT1 isoform that binds with high affinity to a defined DNA target, WT1(-KTS), was diffusely localized throughout the nucleus. In contrast, expression of an alternative splicing variant with reduced DNA binding affinity, WT1 (+KTS), or WT1 mutants with a disrupted zinc-finger domain resulted in a speckled pattern of expression within the nucleus. Although similar in appearance, the localization of WT1 variants to subnuclear clusters was clearly distinct from that of the essential splicing factor SC35, suggesting that WT1 is not directly involved in pre-mRNA splicing. Localization to subnuclear clusters required the N terminus of WT1, and coexpression of a truncated WT1 mutant and wild-type WT1(-KTS) resulted in their physical association, the redistribution of WT1(-KTS) from a diffuse to a speckled pattern, and the inhibition of its transactivational activity. These observations suggest that different WT1 isoforms and WT1 mutants have distinct subnuclear compartments. Dominant-negative WT1 proteins physically associate with wild-type WT1 in vivo and may result in its sequestration within subnuclear structures.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8618823      PMCID: PMC40275          DOI: 10.1073/pnas.92.26.11960

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  RNA processing. Splicing in space.

Authors:  I W Mattaj
Journal:  Nature       Date:  1994 Dec 22-29       Impact factor: 49.962

2.  WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins.

Authors:  J C Reddy; J C Morris; J Wang; M A English; D A Haber; Y Shi; J D Licht
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

Review 3.  Macromolecular domains within the cell nucleus.

Authors:  D L Spector
Journal:  Annu Rev Cell Biol       Date:  1993

4.  E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle.

Authors:  C Sardet; M Vidal; D Cobrinik; Y Geng; C Onufryk; A Chen; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

5.  The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma.

Authors:  S Park; M Schalling; A Bernard; S Maheswaran; G C Shipley; D Roberts; J Fletcher; R Shipman; J Rheinwald; G Demetri
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

6.  Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.

Authors:  S Park; G Tomlinson; P Nisen; D A Haber
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

7.  Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing.

Authors:  S H Larsson; J P Charlieu; K Miyagawa; D Engelkamp; M Rassoulzadegan; A Ross; F Cuzin; V van Heyningen; N D Hastie
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

8.  WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis.

Authors:  C Englert; X Hou; S Maheswaran; P Bennett; C Ngwu; G G Re; A J Garvin; M R Rosner; D A Haber
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

9.  Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues.

Authors:  S Mundlos; J Pelletier; A Darveau; M Bachmann; A Winterpacht; B Zabel
Journal:  Development       Date:  1993-12       Impact factor: 6.868

10.  Intranuclear localization of snRNP antigens.

Authors:  U Nyman; H Hallman; G Hadlaczky; I Pettersson; G Sharp; N R Ringertz
Journal:  J Cell Biol       Date:  1986-01       Impact factor: 10.539

View more
  45 in total

1.  HuR antagonizes the effect of an intronic pyrimidine-rich sequence in regulating WT1 +/-KTS isoforms.

Authors:  Hui Li; Shuai Hou; Tian Hao; Sikandar Azam; Caigang Liu; Lei Shi; Haixin Lei
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

2.  Single-nucleotide polymorphisms in NAGNAG acceptors are highly predictive for variations of alternative splicing.

Authors:  Michael Hiller; Klaus Huse; Karol Szafranski; Niels Jahn; Jochen Hampe; Stefan Schreiber; Rolf Backofen; Matthias Platzer
Journal:  Am J Hum Genet       Date:  2005-12-22       Impact factor: 11.025

Review 3.  Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors.

Authors:  Pamela Nicholson; Hasmik Yepiskoposyan; Stefanie Metze; Rodolfo Zamudio Orozco; Nicole Kleinschmidt; Oliver Mühlemann
Journal:  Cell Mol Life Sci       Date:  2009-10-27       Impact factor: 9.261

4.  Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation.

Authors:  Y Ye; B Raychaudhuri; A Gurney; C E Campbell; B R Williams
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

5.  Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70.

Authors:  S Maheswaran; C Englert; G Zheng; S B Lee; J Wong; D P Harkin; J Bean; R Ezzell; A J Garvin; R T McCluskey; J A DeCaprio; D A Haber
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

6.  A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.

Authors:  R W Johnstone; R H See; S F Sells; J Wang; S Muthukkumar; C Englert; D A Haber; J D Licht; S P Sugrue; T Roberts; V M Rangnekar; Y Shi
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

7.  The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron.

Authors:  Yeou-cherng Bor; Jennifer Swartz; Avril Morrison; David Rekosh; Michael Ladomery; Marie-Louise Hammarskjöld
Journal:  Genes Dev       Date:  2006-05-31       Impact factor: 11.361

8.  RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1.

Authors:  Tadateru Nishikawa; Jonathan M Wojciak; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2020-09-29       Impact factor: 3.162

9.  Sequence features involved in the mechanism of 3' splice junction wobbling.

Authors:  Kuo-Wang Tsai; Wen-Ching Chan; Chun-Nan Hsu; Wen-Chang Lin
Journal:  BMC Mol Biol       Date:  2010-05-07       Impact factor: 2.946

10.  Molecular determinants and evolutionary dynamics of wobble splicing.

Authors:  Jianning Lv; Yun Yang; Heng Yin; Fengjiao Chu; Haitao Wang; Wenjing Zhang; Yaozhou Zhang; Yongfeng Jin
Journal:  Mol Biol Evol       Date:  2009-02-12       Impact factor: 16.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.